Navidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NYSE NAVB opened at $0.05 on Friday. The company has a market cap of $5.00 million, a PE ratio of -0.17 […]
More Stories
Hermès International Société en commandite par actions (OTCMKTS:HESAY) Stock Price Down 1.7% – Here’s What Happened
Hermès International Société en commandite par actions (OTCMKTS:HESAY – Get Free Report)’s share price traded down 1.7% on Thursday ....
Velocity Composites (LON:VEL) Stock Price Down 6.1% – Here’s Why
Velocity Composites plc (LON:VEL – Get Free Report)’s share price dropped 6.1% during mid-day trading on Thursday . The stock...
ProShares Ultra QQQ (NYSEARCA:QLD) Stock Price Down 0.4% – Here’s What Happened
ProShares Ultra QQQ (NYSEARCA:QLD – Get Free Report)’s stock price dropped 0.4% on Thursday . The company traded as low...
Peninsula Energy (OTCMKTS:PENMF) Stock Price Up 12.2% – What’s Next?
Peninsula Energy Limited (OTCMKTS:PENMF – Get Free Report) shares rose 12.2% during trading on Thursday . The company traded as...
Global X MSCI SuperDividend EAFE ETF (NASDAQ:EFAS) Shares Up 0.1% – Still a Buy?
Shares of Global X MSCI SuperDividend EAFE ETF (NASDAQ:EFAS – Get Free Report) were up 0.1% on Thursday . The...
BlackRock (NYSE:BLK) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of BlackRock (NYSE:BLK – Free Report) in a research report report published on Tuesday morning....